DSIJ Mindshare

Leading Hospital Network to Invest Rs 250 Crore in Cutting-Edge Oncology Centre with India’s First Proton Therapy System

The proposed oncology centre, to be established in Hyderabad by FY 2028, aims to enhance access to Proton Beam Therapy, a state-of-the-art cancer treatment.

Manoj Reddy Sama 0 128 Article rating: 3.5

The company is also progressing on its expansion strategy, aiming to add 3,512 beds over the next 3 to 4 years, starting from FY26.

Stocks below Rs 100: Only buyers seen in these scrips on July 21

At the time of market closing on Thursday, the headline equity indices, i.e. Sensex and Nifty 50 were trading flat amidst volatility in the global markets.

Sayali Kotwal 0 7845 Article rating: 3.8

At the time of market closing on Thursday, the headline equity indices, i.e. Sensex and Nifty 50 were trading flat amidst volatility in the global markets.   

Watch out for these penny stocks locked in the upper circuit on June 23

Sensex, after closing in red on Wednesday, opened on a higher note today. It surged 596 points to the 52,419 level at 10.57 am.

Kaustubh Bhosale 0 8730 Article rating: 3.9

During Thursday's opening bell, the Indian markets moved favourably despite conflicting global trends. Notably, on the global front, the rising likelihood of the US economy entering a recession is also a cause of concern with fluctuating crude oil prices serving as the main driver of this fear.

RSS
123
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR